1-5 of 5
Mariateresa Fulciniti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting Acetyl-CoA Carboxylase Suppresses De Novo Lipogenesis and Tumor Cell Growth in Multiple Myeloma

Available to Purchase
Eugenio Morelli, Caroline Fidalgo Ribeiro, Silvia D. Rodrigues, Claire Gao, Fabio Socciarelli, Domenico Maisano, Vanessa Favasuli, Na Liu, Katia Todoerti, Chandraditya Chakraborty, Yao Yao, Mariateresa Fulciniti, Mehmet Samur, Anil Aktas-Samur, Nicola Amodio, Marcello Turi, Francesca Barello, Johany Penailillo, Cesarina Giallongo, Alessandra Romano, Annamaria Gulla, Kenneth C. Anderson, Giorgio Inghirami, Nikhil C. Munshi, Massimo Loda
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (10): 1975–1987.
https://doi.org/10.1158/1078-0432.CCR-24-2000
Published: 15 May 2025
View article titled, Targeting Acetyl-CoA Carboxylase Suppresses De Novo Lipogenesis and Tumor Cell Growth in Multiple Myeloma
Open the PDF for Targeting Acetyl-CoA Carboxylase Suppresses De Novo Lipogenesis and Tumor Cell Growth in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenström Macroglobulinemia

Free
Na Li, Michael A. Lopez, Maria Linares, Subodh Kumar, Stefania Oliva, Joaquin Martinez-Lopez, Lian Xu, Yan Xu, Tommaso Perini, William Senapedis, Erkan Baloglu, Masood A. Shammas, Zachary Hunter, Kenneth C. Anderson, Steven P. Treon, Nikhil C. Munshi, Mariateresa Fulciniti
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (1): 369–377.
https://doi.org/10.1158/1078-0432.CCR-18-1776
Published: 03 January 2019
View article titled, Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenström Macroglobulinemia
Open the PDF for Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in Waldenström Macroglobulinemia in another window
Includes: Supplementary data
Journal Articles

Significant Biological Role of Sp1 Transactivation in Multiple Myeloma

Free
Mariateresa Fulciniti, Samir Amin, Puru Nanjappa, Scott Rodig, Rao Prabhala, Cheng Li, Stephane Minvielle, Yu-tzu Tai, Pierfrancesco Tassone, Herve Avet-Loiseau, Teru Hideshima, Kenneth C. Anderson, Nikhil C. Munshi
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (20): 6500–6509.
https://doi.org/10.1158/1078-0432.CCR-11-1036
Published: 14 October 2011
View article titled, Significant Biological Role of Sp1 Transactivation in Multiple Myeloma
Open the PDF for Significant Biological Role of Sp1 Transactivation in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

A High-Affinity Fully Human Anti–IL-6 mAb, 1339, for the Treatment of Multiple Myeloma

Free
Mariateresa Fulciniti, Teru Hideshima, Claudine Vermot-Desroches, Samantha Pozzi, Puru Nanjappa, Zhenxin Shen, Nipun Patel, Ernest S. Smith, Wei Wang, Rao Prabhala, Yu-tzu Tai, Pierfrancesco Tassone, Kenneth C. Anderson, Nikhil C. Munshi
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7144–7152.
https://doi.org/10.1158/1078-0432.CCR-09-1483
Published: 30 November 2009
View article titled, A High-Affinity Fully Human Anti–IL-6 mAb, 1339, for the Treatment of Multiple Myeloma
Open the PDF for A High-Affinity Fully Human Anti–IL-6 mAb, 1339, for the Treatment of Multiple Myeloma in another window
Journal Articles

The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo

Free
Hiroshi Ikeda, Teru Hideshima, Mariateresa Fulciniti, Robert J. Lutz, Hiroshi Yasui, Yutaka Okawa, Tanyel Kiziltepe, Sonia Vallet, Samantha Pozzi, Loredana Santo, Giulia Perrone, Yu-Tzu Tai, Diana Cirstea, Noopur S. Raje, Christoph Uherek, Benjamin Dälken, Silke Aigner, Frank Osterroth, Nikhil Munshi, Paul Richardson, Kenneth C. Anderson
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (12): 4028–4037.
https://doi.org/10.1158/1078-0432.CCR-08-2867
Published: 15 June 2009
View article titled, The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo
Open the PDF for The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo in another window
Includes: Supplementary data